Welcome to the
Hepatitis B Foundation
Prevention of Perinatal Hepatitis B Transmission in Haimen City, China
March 2 – The Hepatitis B Foundation’s second paper from its successful 3-year public health campaign in Haimen City, China, was published in Vaccine and focused on results from the perinatal HBV program. Over a 12 month period, all pregnant women in the city were tested for hepatitis B (total of 5,407), and those who tested positive were provided education and counseling, and their newborns received the first dose of the HBV vaccine and one dose of HBIG in the delivery room. All newborns of infected moms were then tested at 12 months for evidence of protective surface antibodies from the vaccine. Although inadequate response or nonresponse to HBV vaccine was more common among babies born to HBeAg-positive and/or high viral load mothers, these risk factors did not completely predict non-responsiveness. Read more.
ABIVAX Doses First Patient in ABX203 Phase IIb/III Trial for Treatment of Chronic Hepatitis B
March 2 –ABX203, a therapeutic vaccine, has been dosed in the first patient in a Phase IIb/III clinical trial to assess if it can deliver a significant improvement in the treatment of chronic hepatitis B. Read more.
‘Most’ Cirrhotic HBV Patients Benefit From Adding Adefovir to Lamivudine
March 2 – Response-guided addition of adefovir to lamivudine-based therapy not only maintains long-term viral suppression in Chinese chronic hepatitis B patients with compensated liver cirrhosis, research suggests, but also improves liver function. Read more.
Hong Kong Researcher's Cancer-Test Technology Named in World Top
March 2 – A new method, referred to as "Liquid Biopsy" can detect cancer early using only a few drops of blood, and was developed by a Hong Kong researcher, and named as one of the top 10 breakthrough technologies this year. Read more.
Living With Hepatitis B
Feb 23 - Learning how to mange a hepatitis B diagnosis, and still live a full, active life, is a resource from the Open Education Consortium featuring the interactive learning guide for acute and chronic HBV infection from the Hepatitis B Foundation. Learn more.
Hepatitis B Foundation
Welcomes Two New Board Members
Jan 26 – The HBF is proud to announce that Craig Esterly, engineer and business owner, and Wayne Yetter, pharmaceutical industry executive, have joined its Board of Directors. Both bring broad and deep experience in the healthcare arena, and are joining the Foundation at a time when we are rapidly expanding and accelerating our pace of research into finding a cure for hepatitis B. Read more...
Implementing the Viral Hepatitis Action Plan: The Role of Community Leadership
Jan 19 – Hep B United’s strategic approach and implementation of the Viral Hepatitis Action Plan is described by Kate Moraras, Director, Hep B United, Hepatitis B Foundation and Isha Weerasinghe, Sr. Policy Analyst, AAPCHO. Read more.
Shop 'Til you Drop with AmazonSmile and Support the Hepatitis B Foundation
Do you shop online with Amazon? Make the Hepatitis B Foundation your charity of choice and shop using AmazonSmile – same great selection, prices, and services AND the AmazonSmile Foundation supports the HBF by donating 0.5% of eligible purchases. Learn more here.
Viral Hepatitis Issues Examined at 2014 American Public Health Association (APHA) Annual Meeting
Jan 5 – Hepatitis B and C were among the important public health issues examined at the recent APHA meeting with presentations by Chari Cohen and Kate Moraras of the Hepatitis B Foundation. Read more.
Page last modified March 2, 2015